Cytek Biosciences, Inc. Common Stock (CTKB)

Price$4.09

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-35.54%

Price vs S&P 500 (4W)-11.27%

VGM Score50.49

Market Capitalization$528.19M

All Metrics

P/CF (Annual)22.57x

Book Value / Share (Quarterly)$2.54

P/TBV (Annual)1.99x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.10%

Cash Flow / Share (Quarterly)$-0.10

Price vs S&P 500 (YTD)-27.17%

Gross Margin (TTM)51.70%

Net Profit Margin (TTM)-36.25%

EPS (TTM)$-0.58

10-Day Avg Trading Volume0.81M

EPS Excl Extra (TTM)$-0.58

Revenue Growth (5Y)16.77%

EPS (Annual)$-0.52

ROI (Annual)-19.09%

Gross Margin (Annual)51.84%

Net Profit Margin (5Y Avg)-7.68%

Cash / Share (Quarterly)$2.03

Revenue Growth QoQ (YoY)6.46%

ROA (Last FY)-14.42%

Revenue Growth TTM (YoY)3.61%

EBITD / Share (TTM)$-0.28

ROE (5Y Avg)-4.55%

Operating Margin (TTM)-21.49%

Cash Flow / Share (Annual)$-0.07

P/B Ratio1.61x

P/B Ratio (Quarterly)1.71x

Net Income / Employee (Annual)$-94,800

EV / Revenue (TTM)2.32x

Net Interest Coverage (TTM)4.47x

ROA (TTM)-15.59%

EV / EBITDA (TTM)696.51x

EPS Incl Extra (Annual)$-0.52

Current Ratio (Annual)5.04x

Quick Ratio (Quarterly)3.94x

3-Month Avg Trading Volume0.81M

52-Week Price Return22.46%

EV / Free Cash Flow (Annual)22.53x

Revenue / Employee (TTM)$290,800

Tangible BV / Share (Quarterly)$2.42

P/S Ratio (Annual)2.62x

Asset Turnover (Annual)0.44x

52-Week High$6.18

Operating Margin (5Y Avg)-7.72%

EPS Excl Extra (Annual)$-0.52

CapEx CAGR (5Y)22.00%

26-Week Price Return-27.61%

Quick Ratio (Annual)4.27x

13-Week Price Return-6.62%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)4.69x

Enterprise Value$473.63M

Revenue / Share Growth (5Y)17.33%

Asset Turnover (TTM)0.43x

Revenue / Employee (Annual)$287,000

Inventory Turnover (Annual)2.10x

Pretax Margin (Annual)-14.81%

Cash / Share (Annual)$2.03

3-Month Return Std Dev56.33%

Gross Margin (5Y Avg)57.47%

Net Income / Employee (TTM)$-105,400

ROE (Last FY)-19.47%

Net Interest Coverage (Annual)-0.26x

EPS Basic Excl Extra (Annual)$-0.52

P/FCF (TTM)24.40x

Receivables Turnover (TTM)3.82x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.58

Receivables Turnover (Annual)3.27x

ROI (TTM)-20.30%

P/S Ratio (TTM)2.59x

Pretax Margin (5Y Avg)-4.08%

Revenue / Share (Annual)$1.58

Tangible BV / Share (Annual)$2.53

Price vs S&P 500 (52W)-1.91%

Year-to-Date Return-19.01%

5-Day Price Return-3.54%

EPS Normalized (Annual)$-0.52

ROA (5Y Avg)-3.39%

Net Profit Margin (Annual)-33.02%

Month-to-Date Return-2.39%

Cash Flow / Share (TTM)$-0.06

EBITD / Share (Annual)$-0.26

Operating Margin (Annual)-20.04%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-4.46%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.58

P/TBV (Quarterly)1.80x

P/B Ratio (Annual)1.89x

Inventory Turnover (TTM)2.07x

Pretax Margin (TTM)-17.61%

Book Value / Share (Annual)$2.66

Price vs S&P 500 (13W)-14.88%

Beta1.19x

P/FCF (Annual)24.40x

Revenue / Share (TTM)$1.59

ROE (TTM)-20.77%

52-Week Low$2.90

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.15est. -0.10

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.91

4.00

Industry Peers — Lab Analytical Instruments(24)

Symbol	Value Score	Growth Score	Momentum Score	Price
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.09
AAgilent Technologies Inc.	C	C	B	$135.44
WATWaters Corp	D	C	C	$365.36
ILMNIllumina Inc	D	D	B	$162.32
MTDMettler-Toledo International	D	C	C	$1154.33
RVTYRevvity, Inc.	C	D	C	$98.37
BRKRBruker Corporation	D	D	B	$56.39
BIOBio-Rad Laboratories, Inc.Class A	C	F	B	$294.32
BIO.BBio-Rad Laboratories, Inc. Class B	C	F	B	$304.15
AVTRAvantor, Inc.	B	D	C	$9.16
TXG10x Genomics, Inc. Class A Common Stock	D	C	A	$31.04

About

Cytek Biosciences develops full-spectrum flow cytometry systems that enable high-resolution, sensitive cell analysis at a lower cost than conventional technologies. Its Aurora and Northern Lights platforms leverage advanced fluorescence detection to deliver superior analytical power and flexibility for research and diagnostics applications. The company generates the majority of its revenue from the United States.